Clinical trial
Randomized Study on N-acetylcysteine Treatment and Outcomes in Patients With Advanced Atherosclerotic Heart Diseases and Diabetes Mellitus (RENEWAL)
NCT05908513 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study on N-acetylcysteine Treatment and Outcomes in Patients With Advanced Atherosclerotic Heart Diseases and Diabetes Mellitus (RENEWAL)
- Lead sponsor
- University of Missouri-Columbia
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- October 15, 2021
- Completion date
- October 15, 2021
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis of artery, diabetes mellitus, inflammation, oxidative stress, peripheral artery disease